BioOrbit is developing the world’s first space-based pharmaceutical manufacturing platform to produce high-value protein crystal drugs in microgravity. Enabling the shift from intravenous (IV) to subcutaneous (SC) injection for protein drugs.
BioOrbit
United Kingdom
